Innovotech Inc - Asset Resilience Ratio

Latest as of December 2024: 0.00%

Innovotech Inc (IOT) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CA$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

CA$3.22 Million

≈ $2.33 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Innovotech Inc's Asset Resilience Ratio has changed over time. Check Innovotech Inc (IOT) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Innovotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Innovotech Inc (IOT) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Innovotech Inc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Innovotech Inc Industry Peers by Asset Resilience Ratio

Compare Innovotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	5.66%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
Abivax SA PA:ABVX	Biotechnology	2.34%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
REMEGEN CO. LTD YC 1 F:REG	Biotechnology	16.77%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Innovotech Inc (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Innovotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.00%	CA$0.00 ≈ $0.00	CA$3.22 Million ≈ $2.33 Million	--
2023-12-31	5.60%	CA$68.14K ≈ $49.29K	CA$1.22 Million ≈ $880.02K	-1.08pp
2022-12-31	6.68%	CA$81.64K ≈ $59.06K	CA$1.22 Million ≈ $884.56K	+1.64pp
2021-12-31	5.04%	CA$72.20K ≈ $52.23K	CA$1.43 Million ≈ $1.04 Million	--

pp = percentage points

About Innovotech Inc

V:IOT Canada Biotechnology

Market Cap

$3.54 Million

CA$4.90 Million CAD

Market Cap Rank

#29199 Global

#1351 in Canada

Share Price

CA$0.09

Change (1 day)

+12.50%

52-Week Range

CA$0.08 - CA$0.34

All Time High

CA$0.34